Goldman Sachs’s Apogee Therapeutics APGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $28.6M | Buy |
659,186
+368,487
| +127% | +$16M | ﹤0.01% | 1519 |
|
|
2025
Q1 | $10.9M | Sell |
290,699
-117,320
| -29% | -$4.38M | ﹤0.01% | 2172 |
|
|
2024
Q4 | $18.5M | Buy |
408,019
+250,562
| +159% | +$11.4M | ﹤0.01% | 1841 |
|
|
2024
Q3 | $9.25M | Sell |
157,457
-179,696
| -53% | -$10.6M | ﹤0.01% | 2327 |
|
|
2024
Q2 | $13.3M | Buy |
337,153
+224,161
| +198% | +$8.82M | ﹤0.01% | 1882 |
|
|
2024
Q1 | $7.51M | Buy |
112,992
+85,241
| +307% | +$5.66M | ﹤0.01% | 2278 |
|
|
2023
Q4 | $775K | Buy |
27,751
+17,749
| +177% | +$496K | ﹤0.01% | 3739 |
|
|
2023
Q3 | $213K | Buy |
+10,002
| New | +$213K | ﹤0.01% | 4235 |
|